ESR1 and breast carcinoma: In breast cancer, the impact of oncogenic miRNAs on estrogen receptor expression and activity largely depends on the context of the disease [10] and noteworthy, in advanced stages, usually characterized by a decrease or loss in ER expression, many oncogenic miRNAs can induce ER re-expression [10].